USD 0.09
(10.97%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 9.9 Million USD | -33.96% |
2023 | 15 Million USD | -2.77% |
2022 | 15.43 Million USD | -7.31% |
2021 | 16.64 Million USD | -7.99% |
2020 | 18.09 Million USD | -9.41% |
2019 | 19.97 Million USD | -7.85% |
2018 | 21.67 Million USD | 64.39% |
2017 | 13.18 Million USD | 9.41% |
2016 | 12.04 Million USD | 18.63% |
2015 | 10.15 Million USD | -0.49% |
2014 | 10.2 Million USD | -7.06% |
2013 | 10.98 Million USD | -7.85% |
2012 | 11.91 Million USD | 0.86% |
2011 | 11.81 Million USD | 2.24% |
2010 | 11.55 Million USD | -1.25% |
2009 | 11.7 Million USD | -45.48% |
2008 | 21.46 Million USD | 205.12% |
2007 | 7.03 Million USD | 0.56% |
2006 | 6.99 Million USD | -0.79% |
2005 | 7.05 Million USD | 5.63% |
2004 | 6.67 Million USD | 11.5% |
2003 | 5.98 Million USD | 4.63% |
2002 | 5.72 Million USD | -8.08% |
2001 | 6.22 Million USD | 8.56% |
2000 | 5.73 Million USD | 6.19% |
1999 | 5.4 Million USD | 31.71% |
1998 | 4.1 Million USD | 2.5% |
1997 | 4 Million USD | 37.93% |
1996 | 2.9 Million USD | 16.0% |
1995 | 2.5 Million USD | -13.79% |
1994 | 2.9 Million USD | 7.41% |
1993 | 2.7 Million USD | -3.57% |
1992 | 2.8 Million USD | 12.0% |
1991 | 2.5 Million USD | -7.41% |
1990 | 2.7 Million USD | -10.0% |
1989 | 3 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 2.54 Million USD | -29.14% |
2024 Q3 | 2.38 Million USD | -12.22% |
2024 Q4 | 2.25 Million USD | -5.82% |
2024 Q2 | 2.72 Million USD | 6.9% |
2023 Q1 | 4.11 Million USD | 0.32% |
2023 FY | 15 Million USD | -2.77% |
2023 Q2 | 3.86 Million USD | -6.22% |
2023 Q3 | 3.42 Million USD | -11.21% |
2023 Q4 | 3.59 Million USD | 4.78% |
2022 FY | 15.43 Million USD | -7.31% |
2022 Q1 | 4.09 Million USD | -10.12% |
2022 Q2 | 3.48 Million USD | -15.01% |
2022 Q3 | 3.74 Million USD | 7.61% |
2022 Q4 | 4.1 Million USD | 9.56% |
2021 FY | 16.64 Million USD | -7.99% |
2021 Q1 | 4.24 Million USD | 16.61% |
2021 Q2 | 3.93 Million USD | -7.25% |
2021 Q3 | 3.9 Million USD | -0.83% |
2021 Q4 | 4.55 Million USD | 16.72% |
2020 Q3 | 4.9 Million USD | 6.27% |
2020 Q1 | 4.92 Million USD | 0.85% |
2020 Q2 | 4.61 Million USD | -6.23% |
2020 FY | 18.09 Million USD | -9.41% |
2020 Q4 | 3.64 Million USD | -25.81% |
2019 Q3 | 4.81 Million USD | 0.95% |
2019 Q4 | 4.88 Million USD | 1.35% |
2019 FY | 19.97 Million USD | -7.85% |
2019 Q1 | 5.49 Million USD | 0.34% |
2019 Q2 | 4.77 Million USD | -13.17% |
2018 Q3 | 6.45 Million USD | 13.99% |
2018 Q4 | 5.47 Million USD | -15.15% |
2018 FY | 21.67 Million USD | 64.39% |
2018 Q1 | 4.07 Million USD | 13.34% |
2018 Q2 | 5.66 Million USD | 38.99% |
2017 FY | 13.18 Million USD | 9.41% |
2017 Q4 | 3.59 Million USD | 6.24% |
2017 Q3 | 3.38 Million USD | 7.06% |
2017 Q1 | 3.04 Million USD | -20.64% |
2017 Q2 | 3.16 Million USD | 3.86% |
2016 FY | 12.04 Million USD | 18.63% |
2016 Q4 | 3.83 Million USD | 33.6% |
2016 Q3 | 2.87 Million USD | 5.41% |
2016 Q2 | 2.72 Million USD | 3.89% |
2016 Q1 | 2.62 Million USD | 0.05% |
2015 Q3 | 2.45 Million USD | -0.7% |
2015 FY | 10.15 Million USD | -0.49% |
2015 Q1 | 2.46 Million USD | -1.23% |
2015 Q2 | 2.47 Million USD | 0.11% |
2015 Q4 | 2.61 Million USD | 6.76% |
2014 Q3 | 2.45 Million USD | -3.75% |
2014 FY | 10.2 Million USD | -7.06% |
2014 Q4 | 2.49 Million USD | 1.66% |
2014 Q1 | 2.69 Million USD | -2.43% |
2014 Q2 | 2.55 Million USD | -5.2% |
2013 FY | 10.98 Million USD | -7.85% |
2013 Q4 | 2.76 Million USD | 3.98% |
2013 Q3 | 2.65 Million USD | -6.48% |
2013 Q2 | 2.83 Million USD | 4.19% |
2013 Q1 | 2.72 Million USD | -0.41% |
2012 Q3 | 3.02 Million USD | -2.24% |
2012 Q4 | 2.73 Million USD | -9.68% |
2012 FY | 11.91 Million USD | 0.86% |
2012 Q1 | 3.05 Million USD | 1.89% |
2012 Q2 | 3.09 Million USD | 1.57% |
2011 Q1 | 2.85 Million USD | -0.08% |
2011 Q2 | 2.99 Million USD | 4.93% |
2011 Q4 | 2.99 Million USD | 0.52% |
2011 Q3 | 2.97 Million USD | -0.38% |
2011 FY | 11.81 Million USD | 2.24% |
2010 Q1 | 2.92 Million USD | 2.13% |
2010 Q3 | 2.86 Million USD | -1.26% |
2010 Q4 | 2.85 Million USD | -0.59% |
2010 Q2 | 2.9 Million USD | -0.75% |
2010 FY | 11.55 Million USD | -1.25% |
2009 Q3 | 2.5 Million USD | -19.04% |
2009 Q1 | 3.23 Million USD | -68.1% |
2009 Q2 | 3.09 Million USD | -4.49% |
2009 FY | 11.7 Million USD | -45.48% |
2009 Q4 | 2.86 Million USD | 14.5% |
2008 Q1 | 3.91 Million USD | 101.54% |
2008 Q2 | 3.7 Million USD | -5.41% |
2008 Q3 | 3.69 Million USD | -0.21% |
2008 Q4 | 10.15 Million USD | 174.78% |
2008 FY | 21.46 Million USD | 205.12% |
2007 FY | 7.03 Million USD | 0.56% |
2007 Q3 | 1.69 Million USD | 2.54% |
2007 Q1 | 1.73 Million USD | -5.22% |
2007 Q2 | 1.65 Million USD | -4.81% |
2007 Q4 | 1.94 Million USD | 14.4% |
2006 FY | 6.99 Million USD | -0.79% |
2006 Q4 | 1.83 Million USD | 5.26% |
2006 Q3 | 1.74 Million USD | -0.99% |
2006 Q2 | 1.76 Million USD | 6.28% |
2006 Q1 | 1.65 Million USD | -9.82% |
2005 Q4 | 1.83 Million USD | 6.24% |
2005 Q3 | 1.72 Million USD | -0.83% |
2005 FY | 7.05 Million USD | 5.63% |
2005 Q1 | 1.74 Million USD | 2.95% |
2005 Q2 | 1.74 Million USD | 0.15% |
2004 Q4 | 1.69 Million USD | -1.83% |
2004 Q2 | 1.63 Million USD | 0.16% |
2004 Q3 | 1.72 Million USD | 5.56% |
2004 FY | 6.67 Million USD | 11.5% |
2004 Q1 | 1.62 Million USD | 4.85% |
2003 FY | 5.98 Million USD | 4.63% |
2003 Q2 | 1.46 Million USD | 1.58% |
2003 Q1 | 1.44 Million USD | 6.76% |
2003 Q4 | 1.55 Million USD | 2.42% |
2003 Q3 | 1.51 Million USD | 3.26% |
2002 Q3 | 1.42 Million USD | -1.88% |
2002 FY | 5.72 Million USD | -8.08% |
2002 Q4 | 1.35 Million USD | -4.75% |
2002 Q2 | 1.44 Million USD | -3.02% |
2002 Q1 | 1.49 Million USD | -5.39% |
2001 Q2 | 1.53 Million USD | 7.86% |
2001 Q3 | 1.68 Million USD | 9.58% |
2001 Q4 | 1.58 Million USD | -6.17% |
2001 FY | 6.22 Million USD | 8.56% |
2001 Q1 | 1.42 Million USD | -2.09% |
2000 Q2 | 1.3 Million USD | 8.33% |
2000 Q3 | 1.72 Million USD | 32.78% |
2000 FY | 5.73 Million USD | 6.19% |
2000 Q1 | 1.2 Million USD | -7.69% |
2000 Q4 | 1.45 Million USD | -15.7% |
1999 Q2 | 1.4 Million USD | -6.67% |
1999 Q4 | 1.3 Million USD | 8.33% |
1999 FY | 5.4 Million USD | 31.71% |
1999 Q1 | 1.5 Million USD | 25.0% |
1999 Q3 | 1.2 Million USD | -14.29% |
1998 Q3 | 1 Million USD | -9.09% |
1998 FY | 4.1 Million USD | 2.5% |
1998 Q1 | 1 Million USD | -16.67% |
1998 Q2 | 1.1 Million USD | 10.0% |
1998 Q4 | 1.2 Million USD | 20.0% |
1997 Q4 | 1.2 Million USD | 20.0% |
1997 Q3 | 1 Million USD | 11.11% |
1997 Q1 | 900 Thousand USD | 0.0% |
1997 Q2 | 900 Thousand USD | 0.0% |
1997 FY | 4 Million USD | 37.93% |
1996 FY | 2.9 Million USD | 16.0% |
1996 Q4 | 900 Thousand USD | 50.0% |
1996 Q3 | 600 Thousand USD | 0.0% |
1996 Q2 | 600 Thousand USD | -14.29% |
1996 Q1 | 700 Thousand USD | 0.0% |
1995 FY | 2.5 Million USD | -13.79% |
1995 Q3 | 600 Thousand USD | 0.0% |
1995 Q2 | 600 Thousand USD | -14.29% |
1995 Q1 | 700 Thousand USD | -12.5% |
1995 Q4 | 700 Thousand USD | 16.67% |
1994 Q2 | 600 Thousand USD | -33.33% |
1994 Q1 | 900 Thousand USD | 28.57% |
1994 FY | 2.9 Million USD | 7.41% |
1994 Q4 | 800 Thousand USD | 14.29% |
1994 Q3 | 700 Thousand USD | 16.67% |
1993 Q4 | 700 Thousand USD | 0.0% |
1993 Q1 | 600 Thousand USD | -25.0% |
1993 FY | 2.7 Million USD | -3.57% |
1993 Q2 | 600 Thousand USD | 0.0% |
1993 Q3 | 700 Thousand USD | 16.67% |
1992 Q3 | 700 Thousand USD | 16.67% |
1992 Q2 | 600 Thousand USD | 0.0% |
1992 Q1 | 600 Thousand USD | 0.0% |
1992 Q4 | 800 Thousand USD | 14.29% |
1992 FY | 2.8 Million USD | 12.0% |
1991 Q2 | 600 Thousand USD | 0.0% |
1991 Q1 | 600 Thousand USD | -25.0% |
1991 Q4 | 600 Thousand USD | 0.0% |
1991 Q3 | 600 Thousand USD | 0.0% |
1991 FY | 2.5 Million USD | -7.41% |
1990 Q2 | - USD | 0.0% |
1990 Q4 | 800 Thousand USD | 14.29% |
1990 FY | 2.7 Million USD | -10.0% |
1990 Q1 | - USD | 100.0% |
1990 Q3 | 700 Thousand USD | 0.0% |
1989 Q1 | - USD | 0.0% |
1989 Q2 | - USD | 0.0% |
1989 FY | 3 Million USD | 0.0% |
1989 Q4 | -6.4 Million USD | 0.0% |
1989 Q3 | - USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Acutus Medical, Inc. | 11.22 Million USD | 11.725% |
Biotricity, Inc. | 17.18 Million USD | 42.343% |
Cell MedX Corp. | 313.43 Thousand USD | -3061.161% |
Nemaura Medical Inc. | 7.13 Million USD | -38.791% |
PetVivo Holdings, Inc. | 11.36 Million USD | 12.788% |
RetinalGenix Technologies Inc. | 2.08 Million USD | -374.739% |
Sonendo, Inc. | 68.46 Million USD | 85.528% |
Telesis Bio, Inc. | 63.48 Million USD | 84.394% |
Talis Biomedical Corporation | 67.18 Million USD | 85.253% |
Viveve Medical, Inc. | 22.17 Million USD | 55.315% |